Filter
5493
Filtered Results: 5493
Text search:
drug
addiction
Featured
Recommendations
483
New Publications
1453
Language
Document type
No document type
3349
Studies & Reports
852
Guidelines
656
Manuals
247
Strategic & Response Plan
169
Training Material
79
Fact sheets
76
Situation Updates
24
Resource Platforms
15
Infographics
14
Brochures
8
Online Courses
2
App
1
Videos
1
Countries / Regions
India
349
Global
182
Kenya
165
South Africa
137
Uganda
125
Ethiopia
124
Western and Central Europe
118
Nigeria
109
Tanzania
107
Sierra Leone
93
Zambia
91
Liberia
89
Nepal
87
Malawi
86
Myanmar / Burma
77
Ghana
74
Africa
71
Bangladesh
70
Latin America and the Carribbean
69
Rwanda
63
Eastern Europe
59
Namibia
59
Ukraine
58
Philippines
50
Zimbabwe
43
Asia
41
Cambodia
37
Lesotho
36
South–East Asia Region
36
Russia
30
Botswana
27
Indonesia
27
Mozambique
25
Congo, Democratic Republic of
24
Syria
22
Eswatini/ Swaziland
19
South Sudan
18
Burkina Faso
17
Germany
17
Senegal
16
East and Southern Africa
15
Brazil
15
USA
14
Tajikistan
13
Cameroon
13
Haiti
13
Eastern Europe and Central Asia
13
Colombia
12
West and Central Africa
12
Thailand
11
Guinea
11
Middle East and North Africa
11
Georgia
11
Pakistan
11
Albania
10
Venezuela
10
Vietnam
10
Afghanistan
8
Benin
7
Laos
7
Sudan
7
North Macedonia
6
China
6
Armenia
6
Western Pacific Region
6
North America
6
Moldova
6
Sri Lanka
6
Mexico
5
Lebanon
5
Central African Republic
5
Iraq
5
Timor Leste/ East Timor
4
Turkey
4
Iran
4
Peru
4
Jordan
4
United Kingdom
4
Argentina
4
Yemen
4
Mali
4
Bhutan
4
Somalia
4
El Salvador
3
Fiji
3
Kyrgyzstan
3
Uzbekistan
3
Jamaica
3
Belarus
3
Papua New Guinea
3
Palestine
3
Libya
3
Kazakhstan
2
Chile
2
Canada
2
Estonia
2
Morocco
2
Hungary
2
Belgium
2
Portugal
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Poland
2
Honduras
2
Angola
2
Madagascar
2
North Korea
1
Switzerland
1
Serbia
1
Australia
1
Singapore
1
Malaysia
1
Qatar
1
Bulgaria
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Norway
1
Spain
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Greece
1
Chad
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2111
Clinical Guidelines
463
Public Health
249
Women & Child Health
217
Key Resources
152
Capacity Building
87
Pharmacy & Technologies
68
Annual Report MEDBOX
1
Toolboxes
HIV
659
Mental Health
580
TB
488
AMR
257
NTDs
216
COVID-19
215
Pharmacy
163
NCDs
117
Caregiver
105
Rapid Response
93
Malaria
89
Ebola & Marburg
76
Refugee
74
Planetary Health
71
Disability
63
Conflict
61
Global Health Education
51
Health Financing Toolbox
49
Natural Hazards
22
Cholera
21
Polio
21
Zika
19
Specific Hazards
18
Social Ethics
13
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
2nd edition. The interagency field handbook on malaria control was developed to set out effective malaria control responses in humanitarian emergencies, particularly during the acute phase when reliance on international humanitarian assistance is greatest. This second edition represents a thorough u...
HIV infection, due to the immunosuppressant that leads, nowadays constitutes an aggravating factor of endemic tuberculosis. Tuberculosis remains a huge burden to human health, even in the early 21st century. The situation is deteriorating in many countries, particularly because of the synergy with t...
The aim of the meeting was to broaden the network’s initiatives. Preliminary work involved integrating laboratory testing for skin NTDs other than Buruli ulcer, such as cutaneous leishmaniasis, mycetoma, leprosy and yaws, while extending the network’s reach to encompass additional laboratories.
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
In 2019, the Task Force on Fiscal Policy for Health concluded that taxes on tobacco, alcohol, and sugar-sweetened beverages were a highly effective but greatly underused policy tool to reduce consumption, save lives, and raise domestic resources. The Task Force estimated that if all countries increa...
Zambia has completed the implementation of the National TB Strategic Plan (2017-2021) that set in motion the TB elimination agenda in Zambia through coordinated and accelerated TB response. During this period, the National TB and Leprosy Programme (NTLP) registered tremendous success.
The NTLP is ...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), helps national and local stakeholders to design country-specific social and behavioural change communication (SBCC) campaigns that address the threat posed by substandard, spurious, falsified and fal...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Comprehensive Primary Health Care has an important role in the primary and secondary prevention of several disease conditions, including non-communicable diseases which today contribute to over 60% of the mortality in India. The provision of Comprehensive primary health care reduces morbidity, disab...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
The Transformation Agenda (TA) ushered in an ambitious reform process intended to transform the World Health Organization (WHO) into an organization that is proactive, results-driven, accountable and which meets stakeholder expectations, towards transforming and improving public health services in t...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
